The Health and Environmental Sciences Institute (HESI)’s Cell Therapy - TRAcking, Circulation, and Safety (CT-TRACS) Committee has selected the development of a database as part of its 2018-2020 projects. The selection of this project was based on feedback collected via a stakeholders survey distributed in 2017 to the broader cell therapy sector community. This database is meant to be a free public resource, listing existing case-studies using cell tracking to assess cell fate and the overall safety of the therapy. Your feedback is important to identify key features of such database, in a way that is relevant for the end-users. Please consider taking a moment to answer the following questions and help the cell therapy community at large.
We respect your privacy: The survey does not involve revealing any proprietary data. Respondents have the option to remain anonymous (however, we do ask general background information for demographics purposes - e.g., sector, expertise, etc.)
Questions about the survey can be directed to the HESI CT-TRACS Scientific Program Manager, Dr. Lucilia Mouriès (lmouries@hesiglobal.org).
